COVID antibody

Bio & Pharma Samsung, Celltrion lead biosimilar market in Europe, US

Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...

IPOs Celltrion seeks large-scale M&A in Q4, eyes 2027 Nasdaq debut

SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...

IPOs Sono International seeks IPO in 2025 with $2.1 billion in corporate value

South Korea’s top resort operator Sono International Co. is seeking an initial public offering of its shares on the Korean market next year, r...

Bio & Pharma Celltrion’s Remsima on course to become Korea’s 1st blockbuster drug

Celltrion Inc.'s Remsima, the world’s first biosimilar monoclonal antibody, is on track to exceed 1 trillion won ($713 million) in sales this ...

Bio & Pharma Celltrion to establish CDMO subsidiary

Celltrion Inc., South Korea’s largest biosimilar maker, said on Friday it plans to establish a contract development and manufacturing organiza...

Korean startups Enormous market ahead for Hopae, S.Korean DID pioneer

To Hopae Inc., a digital identity solution-developing startup native to South Korea, its home market is small. After successfully accommodating more...

Bio & Pharma Celltrion eyes M&A in Europe, $3.3 bn Zymfentra sales: chairman

WASHINGTON, D.C. – South Korean biosimilar giant Celltrion Inc. is accelerating its push to transform into a novel drug developer, going after...

Travel & Leisure S.Korea sees record-high foreign visitors after pandemic

South Korea saw a record-high number of foreign tourists post-COVID-19 in the first quarter of 2024. The South Korean Ministry of Culture, Spor...

Travel & Leisure Number of foreign tourists visiting Korea surpasses 11 million in 2023

The number of foreign tourists visiting Korea last year exceeded 11 million, reaching 63% of the pre-COVID level, with over 1 million arrivals month...

Bio & Pharma Celltrion, WuXi XDC to develop new antibody-drug conjugates

South Korea’s Celltrion Inc. has signed a business agreement with China’s WuXi XDC to jointly develop new antibody-drug conjugates (ADC)...

Bio & Pharma Lotte Biologics, NJ Bio to jointly develop ADC

South Korea's Lotte Biologics Co. announced on Monday that it has signed a strategic business agreement with NJ Bio, a US-based preclinical and clin...

Mergers & Acquisitions Orion to buy control of biotech startup LegoChem for $415 mn

South Korea’s snack and confectionery maker Orion Group has agreed to buy a controlling stake in LegoChem Biosciences Inc., a Korean biotech s...

Bio & Pharma SK Bioscience start to deliver Novavax COVID-19 vaccine

South Korea's SK Bioscience Co. announced on Tuesday that it started to deliver the Novavax COVID-19 vaccine against XBB.1.5 variant.According to No...

Bio & Pharma Celltrion, Cyron to develop multi-specific antibody new drug

South Korea’s biopharmaceutical company Celltrion Inc. announced on Wednesday that it signed a joint research agreement with domestic startup ...

Food & Beverage Korea Post resumes kimchi delivery to US

South Korea's state-run postal service agency Korea Post announced on Monday it resumed Express Mail Service (EMS) for shipping kimchi all over the ...

Bio & Pharma 'World-class bispecific antibody technology of ABL Bio'

MADRID - "The clinical Phase 1 results of the immune-oncology candidate ABL111, developed in collaboration with ABL Bio, have been selected as the b...

Bio & Pharma Lotte builds US antibody-drug conjugate plant with $82 mn

South Korea’s Lotte Biologics Co. is establishing an antibody-drug conjugate (ADC) factory in Syracuse, New York, with an investment of 110 bi...

Travel & Leisure S.Korea releases winter schedule for weekly int’l flights

South Korea will expand its number of weekly flights this winter to Japan and Southeast Asia, two regions expected to have high demand that season, ...

Travel & Leisure S.Korean airlines see 12.87 mn int’l passengers in Q3 2023

South Korean airlines’ international passenger traffic in the third quarter reached 85% of that over the same period in 2019, the year befor...

Bio & Pharma HLB gets global rights to Chinese liver cancer drug

South Korea’s HLB Therapeutics Co. on Tuesday said its US subsidiary Elevar Therapeutics has acquired the global rights excluding South Kore...

Airlines Incheon Airport’s cumulative passengers surpass 800 mn

Incheon International Airport, which opened in 2001, has surpassed a cumulative total of 800 million passengers. Incheon International Airport Corpo...

E-commerce Live commerce app Grip aims to expand into Japan, US in 2024

Imagine you're using a shopping app. You talk to the seller, ask questions and receive answers in real-time on a livestream video. Now and then, the...

Airlines Eastar Jet resumes int'l flights after three and half years

South Korea's low-cost carrier Eastar Jet on Sunday said it resumed international flights for the first time in three and a half years starting with...

Beauty & Cosmetics LG H&H's The Whoo unveils Cheongidan renewal line in Shanghai

LG H&H Co. announced on Thursday its strategy to focus on the Chinese market by unveiling a renewal version of "Cheongidan," the flagship produc...

Travel & Leisure Foreign visitors to S.Korea in July surpass 1 mn post-COVID-19

The number of foreign tourists visiting South Korea has exceeded 1 million in a month for the first time since the outbreak of COVID-19. According t...

Bio & Pharma Hanmi Pharm to start global clinical trials for immune-oncology drug

South Korea's Hanmi Pharmaceutical Co. announced on Tuesday that it has received approval for the phase 1 clinical trial plan of the immune-oncology...

Bio & Pharma SK Bioscience buys 6.5 million Novavax shares for $83.4 million

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, said on Wednesday it has signed a deal to buy 6.5 million shares in US vacc...

Fashion S.Korea sees fever for luxury goods wane in post-COVID-19 era

South Korea is seeing a gradual decline in the open run, or the practice of customers standing in line before a brand's opening at a department stor...

Travel & Leisure S.Korea in June sets post-COVID-19 monthly high in foreign visitors

The (South) Korea Tourism Organization (KTO) on Friday said 961,000 foreign visitors came to the country last month, a 321.9% jump from June last ye...

Airlines S.Korea-Japan flights outpace Gimpo-Jeju in H1 2023

As Japan eased its border restrictions at the end of last year, the number of passengers on routes between South Korea and Japan in the first half o...